Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infanrix-Hexa and MenC vaccines in UK infants
NCT01896596Phase 4Completed
- Sponsor
- UK Health Security Agency
- Start
- Jul 2013
- Primary completion
- Apr 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Infanrix Hexa in diphtheria, Tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b infection (Hib), sponsored by UK Health Security Agency. Started Jul 2013; status: completed.
02
Drugs
Infanrix Hexa
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01896596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896596.